PB 84 of 2011
National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 8)1
National Health Act 1953
I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under section 85B of the National Health Act 1953.
Dated 22 November 2011
FELICITY McNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
1 Name of Instrument
(1) This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 8).
(2) This Instrument may also be cited as PB 84 of 2011.
2 Commencement
This Instrument commences on 1 December 2011.
3 Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
[1] Schedule 1, entry for Alendronic Acid
omit from the column headed “Claimed Price”: 29.10 substitute: 29.53
[2] Schedule 1, entry for Alendronic acid with colecalciferol
omit from the column headed “Form”:
equivalent to
[3] Schedule 1, entry for Bleomycin
omit from the column headed “Form”:
(with any determined brand of sodium chloride injection as the required solvent)
[4] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 5 mg
omit from the column headed “Claimed Price”: 9.60 substitute: 9.89
[5] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg
omit from the column headed “Claimed Price”: 13.16 substitute: 13.45
[6] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg
omit from the column headed “Claimed Price”: 15.65 substitute: 15.94
[7] Schedule 1, entry for Erythromycin in the form Capsule 250 mg (containing enteric coated pellets)
omit from the column headed “Claimed Price”: 3.60 substitute: 4.56
[8] Schedule 1, entry for Erythromycin in the form Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL
(a) omit from the column headed “Determined Price”: 2.78 substitute: 4.80
(b) omit from the column headed “Claimed Price”: 5.15 substitute: 7.16
[9] Schedule 1, entry for Erythromycin in the form Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL
(a) omit from the column headed “Determined Price”: 3.68 substitute: 6.11
(b) omit from the column headed “Claimed Price”: 6.06 substitute: 8.49
[10] Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
omit from the column headed “Claimed Price”: 15.46 substitute: 16.80
[11] Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
omit from the column headed “Claimed Price”: 16.82 substitute: 18.75
[12] Schedule 1, entry for Hydrocortisone in the form Cream containing hydrocortisone acetate 10 mg per g, 50 g
omit:
Application
Cortef
1
1.86
1.93
[13] Schedule 1, entry for Imipramine in the form Tablet containing imipramine hydrochloride 25 mg
(a) omit from the column headed “Determined Price”: 1.84 substitute: 5.23
(b) omit from the column headed “Claimed Price”: 4.27 substitute: 7.65
[14] Schedule 1, entry for Indomethacin in the form Capsule 25 mg
(a) omit from the column headed “Determined Price”: 2.34 substitute: 2.61
(b) omit from the column headed “Claimed Price”: 3.23 substitute: 3.49
[15] Schedule 1, entry for Lisinopril in the form Tablet 5 mg [Prinivil 5]
omit from the column headed “Claimed Price”: 9.63 substitute: 9.81
[16] Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Prinivil 10]
omit from the column headed “Claimed Price”: 12.83 substitute: 12.99
[17] Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Prinivil 20]
omit from the column headed “Claimed Price”: 15.30 substitute: 15.48
[18] Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
omit from the column headed “Claimed Price”: 10.59 substitute: 11.13
[19] Schedule 1, entry for Meloxicam in the form Tablet 15 mg
omit from the column headed “Claimed Price”: 15.00 substitute: 15.54
[20] Schedule 1, entry for Mianserin in the form Tablet containing mianserin hydrochloride 10 mg
omit from the column headed “Claimed Price”: 9.42 substitute: 10.66
[21] Schedule 1, entry for Mianserin in the form Tablet containing mianserin hydrochloride 20 mg
omit from the column headed “Claimed Price”: 18.88 substitute: 19.32
[22] Schedule 1, entry for Norethisterone with Ethinyloestradiol
substitute:
Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets
Oral
Brevinor
1
2.18
3.85
Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets
Oral
Brevinor-1
1
2.18
3.85
[23] Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg
omit from the column headed “Determined Price”: 12.50 substitute: 12.41
[24] Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg
omit from the column headed “Determined Price”: 19.89 substitute: 19.75
[25] Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg
omit from the column headed “Determined Price”: 30.95 substitute: 30.60
[26] Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg
omit from the column headed “Determined Price”: 47.58 substitute: 47.29
[27] Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses
(CFC-free formulation)
omit from the column headed “Claimed Price”: 3.78 substitute: 4.23
[28] Schedule 1, entry for Simvastatin in the form Tablet 5 mg
omit from the column headed “Claimed Price”: 14.02 substitute: 14.56
[29] Schedule 1, entry for Simvastatin in the form Tablet 10 mg
omit from the column headed “Claimed Price” (twice occurring): 18.28 substitute: 18.82
[30] Schedule 1, entry for Simvastatin in the form Tablet 20 mg
omit from the column headed “Claimed Price” (twice occurring): 25.01 substitute: 25.57
[31] Schedule 1, entry for Simvastatin in the form Tablet 40 mg
omit from the column headed “Claimed Price” (twice occurring): 35.18 substitute: 35.80
[32] Schedule 1, entry for Simvastatin in the form Tablet 80 mg
omit from the column headed “Claimed Price” (twice occurring): 48.79 substitute: 49.36
[33] Schedule 1, entry for Sucralfate in the form Tablet equivalent to 1 g anhydrous sucralfate
(a) omit from the column headed “Determined Price”: 14.72 substitute: 15.91
(b) omit from the column headed “Claimed Price”: 16.51 substitute: 17.70
[34] Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg
omit from the column headed “Claimed Price”: 10.78 substitute: 11.09
[35] Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg
omit from the column headed “Claimed Price”: 20.83 substitute: 21.23
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.
